BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2933260)

  • 1. Serum beta-N-acetyl hexosaminidase (beta-NAH) as a discriminant between malignant and benign extrahepatic biliary obstruction: comparison with carcinoembryonic antigen (CEA).
    Scapa E; Thomas P; Loewenstein MS; Zamcheck N
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1037-42. PubMed ID: 2933260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta-N-acetyl hexosaminidase and bile acid levels in patients with benign and malignant biliary obstruction.
    Scapa E; Novis BH; Loewenstein M; Thomas P; Zamcheck N
    Dig Dis Sci; 1988 Feb; 33(2):189-92. PubMed ID: 2827973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta-N-acetylhexosaminidase, carcinoembryonic antigen & sialic acid in benign & malignant extrahepatic biliary obstruction.
    Saha NK; Khanduja KL; Bose SM
    Indian J Med Res; 1993 Dec; 98():269-73. PubMed ID: 8132228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of albumin administration in serum liver enzymes of rats in the presence of extrahepatic biliary obstruction.
    Lessa JF; Rangel LS; Costa NJ; Castro e Silva O; Cruz CA; Sousa JB
    Acta Cir Bras; 2011; 26 Suppl 2():70-3. PubMed ID: 22030818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated carcinoembryonic antigen levels and biliary tract obstruction.
    Lurie BB; Loewenstein MS; Zamcheck N
    JAMA; 1975 Jul; 233(4):326-30. PubMed ID: 1173645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholestasis and hepatic metastases: a factor contributing to extreme elevations of carcinoembryonic antigen.
    O'Brien MJ; Bronstein B; Zamcheck N; Saravis C; Burke B; Gottlieb LS
    J Natl Cancer Inst; 1980 Jun; 64(6):1291-4. PubMed ID: 6246298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in CEA values determined by EIA and RIA in patients with benign and malignant biliary obstructions.
    Scapa E; Haagensen DE; Cantarow W; Loewenstein MS; Thomas P; Zamcheck N
    Am J Clin Pathol; 1985 May; 83(5):589-93. PubMed ID: 3887894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states.
    Loewenstein MS; Zamcheck N
    Cancer; 1978 Sep; 42(3 Suppl):1412-8. PubMed ID: 361200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum activity of mitochondrial aspartate aminotransferase and extrahepatic cholestasis].
    Hanny P; Ink O; Goenner S; Boutron A; Buffet C
    Gastroenterol Clin Biol; 1989 Jan; 13(1):66-70. PubMed ID: 2925044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Hexosaminidase level in serum from patients with viral hepatitis as a measure of reticuloendothelial function.
    Hultberg B; Braconier JH; Isaksson A; Jansson L
    Scand J Infect Dis; 1981; 13(4):241-5. PubMed ID: 6458881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum beta-N-acetyl hexosaminidase as a new marker of graft viability in canine orthotopic liver transplantation].
    Tominaga M; Ku Y; Kuroda Y
    Nihon Geka Gakkai Zasshi; 1994 Mar; 95(3):179-86. PubMed ID: 8177200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Hexosaminidase in serum from patients with cirrhosis and cholestasis.
    Hultberg B; Isaksson A; Jansson L
    Enzyme; 1981; 26(6):296-300. PubMed ID: 6458490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical beta-hexosaminidase in sera of cancer patients with liver metastases.
    Alhadeff JA; Prorok JJ; Dura PA; Plucinsky MC; Beesburg RY
    Cancer Res; 1984 Nov; 44(11):5422-6. PubMed ID: 6237719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen in serum in diseases of the liver and pancreas.
    Khoo SK; Mackay IR
    J Clin Pathol; 1973 Jul; 26(7):470-5. PubMed ID: 4727056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein and carcinoembryonic antigen in patients with primary liver carcinoma, metastatic liver disease, and alcoholic liver disease.
    Bell H
    Scand J Gastroenterol; 1982 Oct; 17(7):897-903. PubMed ID: 6186010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of serum tumour markers CEA, CA 50 and CA 242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis; results from a prospective study.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1992; 12(5):1687-93. PubMed ID: 1332581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal enzymes, alkaline phosphatase, and bilirubin in plasma after bile duct transection in the rat.
    Holmberg JT; Hultberg B; Ihse I; Isaksson A
    Scand J Gastroenterol; 1985 Sep; 20(7):868-72. PubMed ID: 4048838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen (CEA) in patients with alcoholic liver diseases.
    Bell H; Orjasaeter H; Lange HF
    Scand J Gastroenterol; 1979; 14(3):273-9. PubMed ID: 441676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
    Aabo K; Pedersen H; Kjaer M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen in normal and diseased liver tissue.
    Gerber MA; Thung SN
    Am J Pathol; 1978 Sep; 92(3):671-9. PubMed ID: 356625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.